Sequent Scientific Limited has announced a conference call with analysts and investors to discuss its Q3FY26 financial results. The earnings call is scheduled for February 6, 2026, at 9:00 AM IST, as communicated to BSE Limited and National Stock Exchange of India Limited on January 21, 2026.

Regulatory Compliance and Announcement Details

The company made this announcement pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal intimation was signed by Yoshita Vora, Company Secretary & Compliance Officer, and submitted to both stock exchanges where the company is listed.

Conference Call Leadership

The Q3FY26 earnings discussion will be led by the company's senior management team, ensuring comprehensive coverage of financial performance and business developments.

Participation Details

Investors and analysts can participate in the conference call using the provided dial-in numbers. The company has made arrangements for universal access and early registration through DiamondPass facility.

Company Information

Sequent Scientific Limited, formerly known as Viyash Scientific Limited, operates in the animal health sector. The company's registered office is located at 3rd Floor, Srivalli's Corporate, Plot No.290, Road No.6, Sy.No.33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India-500033. Additional information and conference call details are available on the company's website in the Investors Section at www.sequent.in .

Sequent Scientific Limited has officially completed its transformation to Viyash Scientific Limited, marking a significant corporate milestone with the formal approval from regulatory authorities. The name change became effective from January 8, 2026, following the receipt of necessary approvals from the Registrar of Companies.

Regulatory Approval and Timeline

The company received the crucial approval from the Registrar of Companies (ROC) for the name change on January 8, 2026. The ROC issued a fresh Certificate of Incorporation on the same date, which was subsequently received by the company on January 9, 2026. This regulatory approval represents the final step in the corporate name change process that began several months earlier.

Shareholder Approval Process

The name change proposal received formal approval from shareholders through a special resolution passed via postal ballot on December 28, 2025. This democratic process ensured that the corporate transformation had the backing of the company's ownership base before proceeding with regulatory formalities.

Corporate Identity Details

The company's Corporate Identification Number (CIN) remains unchanged at L99999TS1985PLC196357, ensuring continuity in regulatory identification. According to the Certificate of Incorporation, the company was originally incorporated as Visistha Trades and Finance Limited before becoming Sequent Scientific Limited, and now operates as Viyash Scientific Limited.

Regulatory Compliance and Next Steps

Viyash Scientific Limited has informed both BSE Limited and National Stock Exchange of India Limited about the completed name change under Regulation 30 of the SEBI Listing Regulations. The company is currently in the process of filing required documents with the stock exchanges for necessary updates to trading systems and records.

Legal Requirements and Obligations

As per regulatory requirements under Section 12 of the Companies Act, Viyash Scientific Limited must display its former name "Sequent Scientific Limited" alongside the new name for a period of two years at all places where the company is required to display its name. This ensures transparency and continuity for stakeholders during the transition period.

The name change does not affect the rights and liabilities of stakeholders, maintaining all existing contractual and legal obligations under the new corporate identity. The company continues to operate from its registered office in Hyderabad and maintains its operational office in Thane, Maharashtra.